We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s


The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
read more

Source: NY Times


20:58, July 2, 2024 Pam Belluck

You may also like

News